A key genetic risk factor in COPD is alpha-1-antitrypsin (A1AT), a serine protease inhibitor involved in protecting the lung from destructive protease actions, particularly that of neutrophil elastase enzymes [37]. The gene discussed is SERPINA1; the disease is chronic obstructive pulmonary disease.